Home/Browse by collection/Adverse effects and drug safety

Adverse effects and drug safety

Showing results 41 - 50 of 77

Sorted by most recent

TitleAuthorDate

MHRA drug safety update: risk of Fournier’s gangrene with SGLT2 inhibitors for diabetes

1 August 2019

New restrictions and precautions for the use of fluoroquinolones

1 August 2019

Renewed safety warnings for yellow fever vaccine

29 July 2019

MHRA drug safety update: hydrochlorothiazide and non-melanoma skin cancer

23 April 2019

MHRA drug safety update: severe and fatal burns risk with emollients

23 April 2019

Oral lidocaine for infant teething reclassified as Pharmacy only

31 January 2019

MHRA Drug Safety Update: denosumab (Xgeva) and rebound hypercalcaemia

20 November 2018

Ulipristal acetate (Esmya): restrictions on use

22 October 2018

▼Valproate medicines - Pregnancy Prevention Programme materials available

1 August 2018

Pathways to faster access to medicines

1 August 2018

Prev 1 2 3 456 7 8 Next